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Abstract
Axon degeneration and axonal loss is a feature of neurodegenerative disease and injury 
and occurs via programmed pathways that are distinct from cell death pathways. While 
the pathways of axonal loss following axon severing are well described, less is known 
about axonal loss following other neurodegenerative insults. Here we use primary mouse 
cortical neuron cultures grown in compartmentalized chambers to investigate the role of 
calcium in the degeneration of axons that occurs following a somal insult by the 
excitotoxin kainic acid. Calcium influx has been implicated in both excitotoxicity and axon 
degeneration mechanisms, however the link between a somal insult and axonal calcium 
increase is unclear. Live imaging of axons demonstrated that pharmacologically 
preventing intracellular calcium increases through the endoplasmic reticulum or 
mitochondria significantly (p<0.05) reduced axon degeneration. Live calcium-imaging 
with the Ca2+ indicator Fluo-4 demonstrated that kainic acid exposure to the soma 
resulted in a rapid, and transient, increase in calcium in the axon, which occured even at 
low kainic acid concentrations that do not cause axon degeneration within 24 hours. 
However, this calcium transient was followed by a gradual increase in axonal calcium, 
which was associated with axonal loss. Furthermore, treatment with a range of doses of 
the microtubule stabilizing drug taxol, which protects against axon fragmentation in this 
model, prevented this gradual calcium increase, suggesting that the intra-axonal calcium 
changes are downstream of microtubule associated events. Biochemical analysis of taxol 
treated neurons demonstrated a shift in microtubule post-translational modifications, with 
a significant (p<0.05) increase in acetylated tubulin and a significant (p<0.05) decrease in 
tyrosinated tubulin, suggestive of a more stable microtubule pool. Together our results 
suggest that axonal degeneration following excitotoxicity is dependent on an increase in 
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Introduction
Axon degeneration occurs in a number of neurodegenerative diseases and it is now clear 
that axons can regulate their own localized or global degeneration independently of 
cellular apoptosis or other known cell death pathways (reviewed in Hilliard 2009; Wang et 
al., 2012). While mechanisms of degeneration following axon severing (Wallerian 
degeneration) have been well described, less is known about axon degeneration 
following pathogenic insults, such as excitotoxicity. We have previously shown that 
excitotoxic stimulation of the cell soma with kainic acid induces axon degeneration in the 
untreated axon, characterized by axon beading and fragmentation as well as caspase 
activation (King et al., 2013). Furthermore, microtubule-stabilizing drugs inhibit axon 
fragmentation implicating microtubule depolymerization in excitotoxin-induced axon 
fragmentation (King et al., 2013).  However, the key events that lead to microtubule 
destabilization in axons following excitotoxic insult to the soma and dendrites are 
currently unclear.
 
One of the key effects of an excitotoxic insult is an increase in intracellular calcium, 
chiefly through NMDA receptors, calcium permeable AMPA receptors or release from 
internal stores (Tymianski & Tator, 1996, Pellegrini-Giampietro et al., 1997, Ruiz et al., 
2009; reviewed in Szydlowska & Tymianski, 2010). Importantly, calcium alterations have 
been shown to be the mediators of the effects of excitotoxicity on the neuron (Cheng et 
al., 1999, reviewed in Arundine & Tymianski, 2004). However, the soma and dendrites, 
where the majority of glutamate receptors are localized, are spatially separated from the 
axon, suggesting that direct excitotoxin-induced calcium influx at the soma and dendrites 
may be unlikely to be the cause of axon degeneration. In spite of this, axonal calcium 
changes are potentially involved in excitotoxin-induced axon degeneration, and calcium 
has been demonstrated to play a role in described forms of axon degeneration including 
Wallerian degeneration and developmental axon pruning.
 
Following severing of an axon, there is a localized increase of calcium in the proximal 
damaged segments (Vargas et al., 2015), which early studies have shown is important 
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followed by a lag phase and a second global calcium increase throughout the severed 
end of the axon (Vargas et al., 2015; Adalbert et al., 2012), which is prevented by 
expression of the Wallerian degeneration protective protein Wlds (Adalbert et al., 2012). 
Inhibition of this second calcium increase delays axon fragmentation. Similarly, 
developmental axon pruning and axonal stretch injury have also been linked to calcium 
changes in the axon (Staal et al., 2010; Yang et al., 2013).
 
The source of calcium involved in signalling cascades in axon degeneration is not well 
described. In the axon, increases in axonal calcium could arise from a number of 
compartments including release from internal stores or influx from the extracellular 
environment. The endoplasmic reticulum (ER) plays an important role in the regulation of 
calcium as a second messenger in the cell and, although not well characterized, is 
present within axons, usually as smooth ER (reviewed in Luarte et al., 2017). The ER 
releases calcium through two main routes, the ryanodine receptors, which are stimulated 
by increases in intracellular calcium (calcium induced calcium release or CICR) and the 
IP3 receptors, which are stimulated by Phospholipase C (reviewed in Mattson et al., 
2000). Axonal ER is tightly coupled to mitochondria (Wu at al., 2017), another 
intracellular source of calcium. Mitochondrial calcium uptake and export through the 
mitochondrial uniporter and the mitochondrial sodium/calcium exchanger are coupled to 
altered energy production (reviewed in Arduino and Perocchi, 2018). However, a key 
mitochondrial calcium exporter in terms of calcium overload and pathological conditions 
is the permeability transition pore (PTP).  Blocking ER calcium release and PTP opening 
have been shown to be protective against Wallerian degeneration-induced axon 
fragmentation (Villegas et al., 2014). Influx of calcium can also occur from the 
extracellular space through voltage-gated calcium channels, TRP channels or reverse 
operation of the sodium/calcium exchanger (Szydlowska and Tymianski, 2010). The 
subtype-specific expression of voltage-gated calcium channels on axon shafts and 
branches is beginning to be described. Chelating extracellular calcium or blocking 
voltage-gated calcium channels have both been shown to delay axon fragmentation 
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In this study we have used a cell culture model, involving the growth of primary murine 
cortical neurons in compartmentalized microfluidic chambers, and live cell imaging to 
investigate calcium signalling in the untreated axon following excitotoxic kainic acid 
stimulation of the somatodendritic compartment. We have investigated the role of calcium 
sources in signalling, as well as the role of calcium in subsequent axon degeneration. 
Furthermore, we investigated whether axonal calcium alterations are up- or down-stream 
of axonal microtubule changes. 
Material and Methods
Animals used in study 
In this study, mice were bred at the Central Farm Facility (University of Tasmania). 69 
time-mated C57BL/6J mice (217 embryos) were used to derive cells for primary culture. 
Each independent culture preparation was derived from the combined embryos of a 
single time-mated mouse. Tissue from these mice contributed to other projects.  All use 
of animals was approved by the animal ethics committee of the University of Tasmania 
(A0015121 and A17530) and performed in accordance with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes developed by the 
National Health and Medical Research Council. Randomization and sample calculations 
were not carried out. This study was not pre‐registered. 
 
Primary cell culture in microfluidic chambers 
Primary mouse cortical cell culture was performed as we have described previously 
(Hosie et al., 2012, King et al., 2013). Cortical neurons were prepared from 217 
embryonic day 15.5 embryos of either sex. The pregnant females (the dams) were 
asphyxated using CO2, which is a method of humane killing recommended by 
ANZCCART (Australian and New Zealand Council for the Care of Animals in Research 
and Teaching) and embryos were removed and decapitated. Cortical tissue was 
dissected from mouse embryos and dissociated using 0.0125% trypsin (5 minutes at 
37°C). Tissue was mechanically triturated in cell plating media consisting of Neurobasal 
media (Gibco, catalog #21103049), 2% B27 supplement (Gibco, catalog #17504044), 0.5 
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antibiotic/antimycotic (Gibco) using a 1ml pipette. Cell viability and density was assessed 
using a trypan blue exclusion assay. Cells (1.2x 105 per chamber) were plated into the 
somatodendritic compartment of a 450 m microfluidic chamber (Xona, catalog #SND450) 
coated with poly-L-lysine substrate (0.001%, Sigma, catalog #P4707) or directly onto 
13mm poly-L-lysine coated coverslips (30,000 cell per coverslip).  Cells were allowed to 
adhere to the substrate for 30 minutes prior to filling chambers with cell plating media. 
The following day, media was changed to cell maintenance media consisting of plating 
media without the fetal calf serum and glutamate. Cells were grown in 5% CO2 at 37°C.
Calcium imaging of cultured cortical neurons
For cytosolic calcium measurements, the membrane permeable fluorescent Ca2+ 
indicator Fluo-4  Direct (Invitrogen, catalog #F10471) was used. Cortical neurons of 
relative maturity (9 DIV) were loaded with 2x Fluo-4 Direct stock solution to the cell 
culture media and incubated for 1 hour in a 5% CO2-humidified incubator at 37°C. Time-
lapse imaging was performed using a Nikon TiE motorized inverted microscope (Nikon, 
Tokyo, Japan). For short (2 mins) calcium imaging recording, cell culture media was 
replaced by Hanks' Balanced Salt solution (HBSS, Gibco), and images were captured 
either every 400 msec with a 20x air objective lens or every 1 sec with a 40x air objective. 
For longer term (60 mins/90 mins) calcium imaging recording, cell maintenance media 
was used for imaging and images were captured every 2 mins using a 40x air objective 
lens. After one-minute of baseline recording, kainic acid ( Sigma, catalog #K0250) 
solution was added to the somatodendritic compartment by pipetting. Calcium activity 
was measured as the average pixel intensity (F) in a randomly selected region of the 
axonal compartment and identical regions (100µm x 100µm) were analysed in all 
experiments. Graphs representing calcium changes were calculated as relative 
fluorescence changes compared to fluorescence intensity at the beginning (F0) according 
to the following formula: (F-F0)/F0. Signal intensities were determined using Fiji software 
(Plot Z-axis profile). To plot changes of calcium intensity over 60-90 mins, the average 
intensity values from images collected every 2 mins were used. For quantification of Ca2+ 
peak intensity, the time point showing the highest signal intensity after kainic acid 
treatment was used. Data were collected from three arbitrary fields per recording, from a 
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Pharmacological manipulation 
Unless otherwise indicated, cells were treated with 50 M kainic acid or vehicle control at 
DIV 9 corresponding to a time of dense axonal growth in the axon chamber. For dose-
dependent experiments, 100 M, 50 M, 25 M, 12.5 M or 5 M kainic acid was added 
to the cells as indicated.   
For intracellular calcium chelation and calcium channel inhibition, 6 M BAPTA -AM 
(Invitrogen, catalog #B6769), 10 M 2-aminoethoxydiphenyl borate (2APB, Sigma, 
catalog #D9754), 10 M Dantrolene sodium salt (Sigma, catalog #D9175) or 10 M 
Cyclosporin A (Sigma, catalog #30024) was added to the axonal chamber along with 
Fluo-4, one hour before imaging. For extracellular calcium chelation, 1mM EGTA (Sigma, 
catalog # E3889) was added to the imaging medium, as indicated. 
To block the action potential, 1 M Tetrodotoxin (Sigma, catalog #T8024) was added to 
the axonal chamber along with Fluo-4, one hour before imaging. To stabilize 
microtubules, 1000, 100 or 10 ng/ml Taxol (Sigma, catalog #T7402) was added to the 
axonal chamber along with Fluo-4, one hour before imaging. 
ELISA Analysis 
 
Cortical neurons were grown in microfluidic chambers for 9 days in vitro prior to treatment 
with10 ng/ml taxol for 2 hours. Plating media was removed from cortical neurons, and 
cultures were rinsed with HBSS. Cells were harvested with RIPA buffer with 
protease inhibitors (Roche, catalog # 4693159001) and phosphatase inhibitors (A.G. 
Scientific, catalog #P-1517). Samples were centrifuged at 13,000 rpm for 1 min and 
pellets were discarded. Samples were diluted at 1:300 in 50 μl carbonate/carbonate 
coating buffer (Abcam, catalog #ab210899), added to a 96-well plate and incubated 
overnight at 4°C. For the standard curve, protein samples were serially diluted at 1:100, 
1:200, 1:400, and 1:800. A blank and no primary control were incubated to correct for 
ELISA results. Plates were washed with washing buffer (0.01M PBS with 0.05% tween-
20) prior to blocking with blocking buffer (0.01M PBS with 5% fetal bovine serum) and 
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antibodies (acetylated tubulin 1:500, mouse, Sigma, catalog #T7451;  tyrosinated tubulin 
1:500 rabbit, Millipore, catalog #ABT171) diluted in blocking buffer for 1h at room 
temperature. Plates were washed and incubated with species-specific HRP secondary 
antibody (DAKO) diluted in blocking buffer at 1:2,000 and incubated at room temperature 
for 45 min. Plates were washed and incubated with room temperature 
tetramethylbenzidine (TMB) substrate (Thermo Scientific, Lot # SA2328991) for 15 min. 
The reaction was stopped by 0.1M H2SO4. Plates was read using plate reader at 450 




Live imaging of axons was acquired on a Nikon TiE motorized inverted microscope, with 
chambers maintained at 37°C. For quantitation of axon degeneration, images were 
acquired of the axonal compartment prior to cell treatment and from an identical area at 
18 hours after treatment. The axon degeneration of primary cortical neurons was 
quantitated by an observer blinded to experimental settings during axon counting. Five 
arbitrarily chosen images for each coverslip, total 6-8 coverslips, collected from three-four 
independent cell cultures were taken for quantification. Beaded and/or fragmented axons 
were scored as evidence of degeneration. Numbers of degenerated axons were 
normalized to pre-treated counts for each image. Degenerated axons were divided by the 
total number of axons for the percentage degeneration. 
  
Statistics
All statistical analysis and graphs were prepared in GraphPad Prism (7.0). Prior to data 
analysis, outliers were designated as data points outside the 95% confidence interval and 
would be excluded from the data analysis. Data are given as mean ±SEM. Statistical 
differences were calculated using one-way ANOVA followed by Dunnett's multiple 
comparisons test; significance was considered at p < 0.05. The normality of data was not 
evaluated. No animals were specifically excluded. Cultures were excluded if they did not 
grow through the microfluidic channels, or if there was evidence of neurodegeneration 
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Results
1. Somal kainic acid exposure results in a rapid calcium transient followed by a 
gradual increase in calcium in the untreated axon
 
In order to determine the effect of somatodendritic kainic acid exposure on axonal 
calcium, we performed live imaging with the fluorescent calcium indicator Fluo-4 which 
provided a sufficient dynamic range to observe rapid and discrete calcium alterations in a 
spatio-temporal manner (Figure 1A). In untreated cultures, occasional calcium transients 
were seen in individual axons (Figure 1B). To induce excitotoxicity, we applied 50 M 
kainic acid, a concentration we have previously shown to induce moderate axon 
degeneration (King et al., 2013), to the somatodendritic compartment of the chamber, 
and imaged calcium transients in the axonal compartment. Exposure to kainic acid 
induced a rapid (within 5 sec) increase in calcium across the axonal compartment . 
These calcium transients reached the highest amplitude and returned to baseline within 
20 sec (Figure 1A, C).  Qualitative analysis of these transients demonstrated that calcium 
increases were present in the majority of axons. The rapid calcium peak was followed by 
a gradual calcium increase in the untreated axons, which reached a steady phase about 
60 minutes following kainic acid application (Figure 1D, F). A weak calcium increase was 
observed in the sham control during the lag phase, potentially due to the stress of the 
cells during recording. Interestingly, the calcium amplification in the gradual phase was 
higher than the first peak (Figure 1E) and was accompanied by the focal swelling of 
axons (Figure 1F). 
 
2. Relationship between kainic acid induced axon degeneration and intra-axonal 
calcium increase. 
We next examined the dose range of kainic acid that resulted in axon degeneration and 
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M of kainic acid were applied to the somatodendritic compartment and the amount of 
axon degeneration examined 18 hours later. 
Qualitatively, 100 M kainic acid induced extensive axon fragmentation, whereas 50 M 
and 25 M kainic acid induced degrees of axon beading with partial fragmentation 
(Figure 2A). Quantitative analysis of axon degeneration demonstrated that while 
significant axon degeneration (beading and fragmentation) was present from 25 M to 
100 M kainic acid, at concentrations below 25 M (12.5 M, 5 M) kainic acid, no 
significant (p<0.05) axon degeneration was present compared with the control group 
(Figure 2A, B). 
To determine the relationship between kainic acid dose and calcium influx, we imaged 
axonal calcium influx over a range of concentrations of kainic acid from 5-100 M. For 
the fast phase of calcium increase, 5 M kainic acid was not sufficient to induce a 
calcium influx in the axons, however concentrations of kainic acid at or above 12.5 M 
induced a significant increase in axonal calcium. The calcium influx in the axon was not 
dependent on the concentration of kainic acid, with conentrations from 12.5 M -100 M 
inducing similar calcium amplitudes, suggesting a threshold response. These data 
suggest that somatodendritic exposure to kainic acid induces an influx of cytoplasmic 
calcium along the untreated axon that is an all-or-nothing response (Figure 2 C). Since 
12.5 M kainic acid induced a rapid calcium transient but did not result in axon 
degeneration, this implies that the initial kainic acid induced calcium transient is unlikely 
to be sufficient to cause axon degeneration. Concentrations of kainic acid at or above 25 
M induced a significant increase in axonal calcium as compared to the vehicle control 
(Figure 2D). The sustained phase of calcium increase in axons showed a similar dose 
related pattern with axon degeneration, which suggests that the gradual axonal calcium 
increase plays a more important role in axon degeneration. 
3. Regulation of the two phases of calcium increase
To assess whether the calcium increases are coupled with action potentials, 1 M of 
tetrodotoxin was added to the axonal compartment while the somal compartment was 
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addition of  tetrodotoxin one hour prior to kainic acid treatment (Figure 3A, C), and the 
gradual calcium increase was attenuated during 90 mins of kainic acid exposure (Figure 
3B, D, E), suggesting the action potential plays a role in triggering calcium influx and that 
the gradual calcium increase may be partially dependent on the fast calcium increase.   
We have previously implicated microtubule-dependent processes in axon degeneration, 
and shown that microtubule stabilization with taxol in the axonal compartment inhibits 
kainic acid induced axon degeneration (King et al., 2013).  To determine the relationship 
between microtubule destabilization and calcium influx, we added taxol to the axonal 
compartment one hour prior to kainic acid treatment. The fast calcium rise was not 
affected by pre-treatment with taxol (Figure 3A, C), however, the gradual calcium 
increase was significantly reduced compared to the vehicle control (Figure 3B, D, E) and 
was not significantly different from untreated cultures (see Figure 1D).To further 
determine the concentration range that taxol is able to prevent the gradual calcium 
increase after kainic acid treatment, the effects of 100 ng/ml and 10 ng/ml axonal taxol 
were tested by calcium imaging. Both 100 ng/ml and 10 ng/ml axonal taxol reduced the 
gradual calcium increase significantly, as compared to vehicle control (Figure 3 F, G).  
These results indicate that microtubule associated events play a role in the gradual 
increase of calcium in the axon, but not in the fast phase of calcium influx.
To further investigate microtubule alterations that may be responsible for this effect on 
the gradual calcium influx, we next investigated changes in microtubule post-translational 
modifications following taxol application to cortical neurons growing on coverslips. ELISA 
analysis demonstrated that 2 hours after 10 ng/ml taxol treatment, acetylated tubulin 
levels were significantly up-regulated and tyrosinated tubulin levels were down-regulated 
(P<0.05). These data suggest that taxol pre-treatment increases the stabilization of 
neuronal microtubules (Figure 3, H, I). 
4. Chelating intra-axonal calcium prevents axon degeneration
To investigate the role of intracellular and extracellular calcium in axon degeneration, we 
used EGTA and the cell permeant BAPTA-AM to chelate extracellular and intracellular 
calcium, respectively. While both calcium chelators caused a significant (P<0.05) 
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to the vehicle control (Figure 4C, D, E), axon degeneration was only significantly altered 
by the addition of BAPTA-AM, with no significant (p<0.05) effect of EGTA. We therefore 
investigated the source of intracellular calcium that results in axonal calcium increases 
and axon degeneration.
   
5. Somatodendritic kainic acid exposure induces calcium release from axonal 
ER and mitochondria 
In axons, most calcium is stored in the ER or mitochondria. To clarify the role of 
intracellular calcium stores in kainic acid induced axonal calcium transients, the fast 
calcium signal was examined in the presence of specific calcium channel blockers 
applied to the axonal compartment. Ryanodine and IP3 receptors were blocked using 
dantrolene or 2APB, respectively, to examine the contribution of the ER calcium channels. 
To examine mitochondrial calcium channel, the mitochondrial permeability transition pore 
(MPTP) was blocked using Cyclosporin A. While 2APB had little effect on the fast calcium 
transient, both dantrolene and Cyclosporin A significantly reduced the amount of 
cytoplasmic calcium in the axon (Figure 5 A, B). These data suggest that the fast calcium 
transient is dependent on a combined release of calcium from ER and mitochondrial 
stores.
We then asked whether the ER and mitochondrial calcium stores also contribute to the 
gradual axonal calcium increase after somatodendritic kainic acid exposure. Dantrolene 
and Cyclosporin A, which reduced the fast calcium increase, also significantly reduced 
the gradual phase calcium increase (Figure 5C, D). The quantification of the calcium 
peak intensity of gradual phase calcium signals showed a drastic decrease in the 
presence of dantrolene or Cyclosporin A in the axonal compartment (Figure 5E). These 
data suggest that calcium released from axonal ER and mitochondria contribute to kainic 
acid induced axonal calcium increase. 
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We next asked whether blocking intra-axonal calcium release could prevent axon 
degeneration induced by somatodendritic kainic acid exposure. Axons were pre-
incubated for 1 hour with Dantrolene and Cyclosporin A, respectively. Axon degeneration 
was quantitated at 18 hours post kainic acid treatment. Axon protection was observed 
when axons were pre-incubated with either dantrolene or Cyclosporin A. These results 
suggest that the intra-axonal calcium release from ER and mitochondria contributes to 
axon degeneration induced by somatodendritic kainic acid exposure (Figure 5F, G).
 
 Discussion
Axon degeneration is a key feature of a number of neurodegenerative diseases including 
amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s disease (reviewed in 
Vickers et al., 2009). Although the cause of axon degeneration in these diseases is 
unclear, excitotoxicity is a key pathological mechanism implicated in disease progression 
and a potential cause of axonal loss (reviewed in King et al., 2016; Wang and Reddy, 
2017). Disease associated excitotoxicity can be mediated through NMDA or 
AMPA/kainate receptors and the specific source of excitotoxicity may differ between 
diseases (e.g Wang and Reddy, 2017; Heath and Shaw 2002).  We have previously 
shown that exposure of the somatodendritic compartment of cultured cortical neurons to 
the excitotoxin kainic acid, an AMPA/kainate receptor agonist, induces degeneration in 
the untreated axon (King et al. 2013). Furthermore, kainic acid induced axon 
degeneration was inhibited by application of the microtubule stabilizing drug taxol to the 
axon (King et al. 2013).  This project sought to investigate the role of axonal calcium 
signalling, implicated in excitotoxin-induced cell death (Arundine and Tymianski, 2003), 
and the relationship to microtubule changes, in downstream axon degeneration pathways. 
We hypothesized that calcium signalling from the soma to the axon could be involved in 
initiating a sequence of changes resulting in axon fragmentation. We show that an initial 
somatodendritic excitotoxic insult with kainic acid results in a rapid calcium influx in the 
axonal compartment, which occurs even at low concentrations of kainic acid that do not 
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by a gradual calcium rise in the axon, which is dose dependent. Application of taxol to the 
axonal compartment, which we have previously shown to prevent axon fragmentation, did 
not affect the initial calcium transient, but prevented the gradual calcium increase. 
Chelation of intracellular calcium prevented axon degeneration and was linked to release 
of calcium from endoplasmic reticulum (through ryanodine receptors) and through the 
mitochondrial permeability transition pore. These data suggest that excitotoxicity applied 
to the somatodendritic compartment induces a rapid, but non-pathologic calcium transient 
and that axon degeneration is dependent on a second gradual increase in calcium from 
internal stores, which is downstream from microtubule-associated processes.
Somatodendritic exposure to kainic acid induces an axonal calcium transient 
followed by a gradual rise in calcium
Our data show that application of kainic acid induced a rapid calcium transient in the 
axonal compartment, which was tetrodotoxin dependant and appeared to progress in an 
“all or nothing” fashion at concentrations tested above 5 µM. This suggests that the initial 
calcium transient is linked to the action potential. A number of pieces of evidence suggest 
that this initial calcium transient is not sufficient to induce axonal degeneration. Firstly, 
this initial calcium transient occurred even at relatively low concentrations of kainic acid 
(12.5 µM); concentrations that did not result in axonal fragmentation over the time-course 
examined. Secondly, the initial calcium transient was still present in the presence of taxol, 
which we have previously shown protects against axon fragmentation.
The initial calcium transient was followed by a more gradual calcium rise which peaked at 
about 60 minutes following exposure to kainic acid. The second calcium increase was 
dose-dependent, and like the first calcium peak was blocked by tetrodotoxin, implicating 
sodium channels and the action potential. However, unlike the first peak, the second 
calcium increase was blocked in the presence of taxol, suggesting mechanistic 
differences to the first calcium peak and that this calcium increase plays a role in the 
induction of axon degeneration processes. Our data are in line with previous studies that 
have investigated calcium alterations in other forms of axonal injury, particularly Wallerian 









This article is protected by copyright. All rights reserved
sensory axons undergoing Wallerian degeneration and demonstrated an initial localized 
benign calcium influx, which was followed by a terminal calcium rise prior to 
fragmentation (Vargus et al., 2015). Similar effects have been reported in cultured 
neurons following transection (Villegas et al., 2014), where expression of the wlds protein 
did not affect initial calcium increases but prevented the later calcium rise and 
downstream degeneration (Adalbert et al., 2012). Furthermore, axonal calcium increases 
have previously been associated with glutamate excitotoxicity, which was shown to 
induce an initial axonal calcium increase followed by a gradually increase over the next 
90 minutes (Hernandez et al., 2018). In this study no transient calcium influx was 
reported, potentially reflecting differences in the age or type of the neurons, which were 
less mature (7-8 days in vitro), potentially prior to action potential induction.
To determine the role of the calcium increases in axon degeneration we utilized the 
calcium chelators EGTA, to chelate extracellular calcium, and the cell permeant BAPTA-
am to chelate intracellular calcium.  Both EGTA and BAPTA-am prevented or reduced 
both the first and second calcium increase within the axonal compartment, however, 
surprisingly, only BAPTA protected against axonal degeneration. There are a number of 
potential explanations for the alterations to intracellular calcium in the presence of 
extracellular EGTA. Firstly, extracellular removal of calcium could deplete the intracellular 
stores. Stys and Lopachin (1998) demonstrated that exposure of optic nerves to a 
perfusate lacking calcium reduced total axoplasmic calcium (which included regions of 
ER) to undetectable levels (Stys and Lopachin, 1998). This suggests a robust exchange 
of the majority of axonal calcium with the extracellular space in optic fibres, although 
other fibre tracts may be more resistant to this calcium depletion (Ouardouz et al., 2003). 
Alternatively, release from intracellular stores could be dependent on an initial 
extracellular calcium signal through calcium channels in the cell membrane as occurs in 
calcium induced calcium release (CICR). The differential effects of BAPTA and EGTA on 
axon degeneration, despite both reducing intracellular calcium levels, is less clear but 
has been previously described (see Matolcsi and Giordano, 2015). For example, Villegas 
and colleagues demonstrated that mitochondria in sciatic nerve explants were 
differentially affected by intracellular or extracellular calcium chelation, with mitochondrial 
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that induction of axon degeneration via intracellular calcium release is dependent on 
subtle calcium changes at specific calcium sensitive nanodomains rather than global 
intracellular calcium. In this regard, BAPTA is a fast calcium blocker, whereas 
extracellular EGTA may reduce intracellular calcium, but not in quantities that are 
sufficient to block these nanodomain effects. BAPTA-am has also been shown to prevent 
axon degeneration in hippocampal slice cultures exposed to ischemic injury (Tymianski et 
al., 1994; Abdel-Hamid and Tymianski, 1997). 
Calcium influx is sodium channel dependent and involves calcium release from ER 
and mitochondria
To investigate the source of calcium we used channel blockers and examined the effect 
on calcium increases in response to kainic acid. Both the initial calcium increase and 
subsequent gradual calcium rise were blocked by tetrodotoxin, indicating dependence on 
sodium channels. Sodium channel opening is intimately linked to the action potential and 
occurs in response to a change in membrane potential. Increases in intracellular sodium 
could induce increases in axonal calcium via a number of mechanisms. Several studies 
have implicated voltage gated calcium channels (VGCC) in rapid calcium influx following 
the action potential, which is dependent on sodium influx, in both peripheral and central 
neurons, although the type of VGCC involved may vary with cell type. Barzan and 
colleagues demonstrated calcium transients in peripheral nerves that were dependent on 
both N and L-type VGCC (Barzan et al., 2016). Furthermore, Jackson et al (2001) 
demonstrated a VGCC dependent calcium increase in sympathetic nerves which was 
tetrodotoxin dependent. However, this calcium increase did not involve intracellular 
stores. Callewaert et al., (1996) examined cerebellar Purkinje cells and showed an 
involvement for P type channels in calcium increases. Sargoy et al., (2014) suggested 
that L-type channels were involved in retinal ganglion cell calcium influx. Another 
potential source of sodium induced calcium influx is the sodium/calcium exchanger. This 
axolemmal ion exchanger usually functions to remove calcium from the cell along the 
electrochemical gradient of sodium; however, during high intracellular sodium it can 
operate in reverse (Yu and Choi, 1997). This reverse operation of the sodium/calcium 
exchanger has been shown to occur in axons under conditions of hypoxia (Stys and 
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calcium release from intracellular stores. Nikolaeva and colleagues showed that unlike 
the in vivo situation, in vitro ischemia to the optic nerve induces a sodium dependent 
release of calcium from intracellular stores involving both ER (ryanodine and IP3 
receptors) and mitochondrial sodium/calcium exchange (Nikolaeva et al., 2005). There is 
also evidence that ryanodine receptors can be directly modulated by sodium ions in the 
sarcoplasmic reticulum of skeletal muscle (Allard and Rougier, 1992; Hu et al., 2003). 
The current study suggests that both action potential derived calcium transients and axon 
degeneration associated secondary calcium flux following excitotoxic injury involves 
calcium release through the ryanodine receptors as well as stimulating calcium release 
through the mitochondrial permeability transition pore. Blocking either of these channels 
provides some protection from axon degeneration. It should be noted however that 
cyclosporin A, used in this study to block mitochondrial calcium efflux, has known off-
target effects such as blocking the activation of calcineurin, implicated in cytoskeletal 
breakdown (Matsuda and Koyasu, 2000). Previous research has implicated action 
potential derived calcium release through ryanodine receptors in axon – oligodendrocyte 
communication, stimulating glutamate release from the axo-myelinic synapse (Micu et al., 
2016). The involvement of MPTP in calcium release following the action potential is less 
expected, however previous studies have shown that pore opening is not always 
associated with degenerative pathways and transient opening of the pore has been 
implicated in somatic reprogramming (Ying et al., 2018) and in acute ischemic 
preconditioning of cardiomyocytes, which can protect against subsequent sustained 
ischemia (Hausenloy et al., 2009). The axonal ER and mitochondria are closely coupled 
(Wu et al., 2017) and previous studies demonstrate the role of ER calcium release in 
mediating MPTP opening following a variety of insults (Villegas et al., 2014). Together, 
our data adds to previous data in the field suggesting a complex involvement of 
intracellular and extracellular calcium in mediating axon degeneration which may depend 
on the amount/duration of the calcium increase as well as cell type specific involvement 
of different calcium channels.
The microtubule stabilizing drug taxol acts upstream of the gradual calcium influx 
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Our previous studies have shown that stabilizing microtubules with taxol significantly 
inhibits axon fragmentation following excitotoxic injury, however the time-course of 
microtubule dependent processes following the somatodendritic excitotoxic insult are not 
known. We hypothesized that microtubule alterations would be downstream of 
intracellular calcium increases. Previous studies have implicated microtubule breakdown 
in axon degeneration resulting from a variety of insults and these processes have been 
linked to calcium dependent processes. For example, O’Brien (1997) demonstrated that 
extracted microtubules can undergo spontaneous depolymerization with high calcium 
level. Furthermore, calcium may activate calpains which can act to degrade microtubule 
associated proteins (MAPs), which could indirectly cause microtubule breakdown (Zhang 
et al., 2007; Ferreira and Bigio, 2011). Conversely some studies suggest that microtubule 
destabilization is upstream of MAP degradation in axons and dendrites (Li et al., 2003, 
Hoskison and Shuttleworth 2006). In discordance with our hypothesis, stabilization of 
microtubules with taxol, even at low concentrations, prevented the second, potentially 
pathological, calcium increase, suggesting that microtubule associated events are 
upstream of calcium increases. To further investigate the role of taxol in preventing the 
calcium influx, we examined the effect of 10ng/ml taxol on microtubule post translational 
modifications. Exposure to taxol resulted in decreased microtubule tyrosination and 
increased acetylation, as has previously been shown in cancer cell lines (Dowdy et al., 
2006). One potential explanation for the taxol induced protection is that the secondary 
calcium increase could be dependent on a microtubule signalling event, which is inhibited 
by the stabilized microtubules. Microtubules are polymers of alpha and beta tubulin 
subunits and their highly dynamic properties and role in transport makes them an ideal 
candidate for the spatial organization of signal transduction molecules within different 
parts of the cell (Gunderson and Cook 1999). There are a number of ways whereby 
microtubules could mediate signal transduction, including binding, release or transport of 
signalling molecules, and these may be affected by alterations in microtubule dynamics, 
such as stabilization with taxol. Our previous studies and those of others suggest a role 
for soma- axonal signalling in excitotoxin-induced axon degeneration (King et al., 2013). 
Alternatively, taxol may result in a more localized effect, such as the uncoupling of 
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requires close coupling of ER and mitochondria, which are strategically positioned by 
mitochondrial transport and held in place by tethers (Rizzuto et al., 1998). Previous 
studies have implicated cytoskeletal modification in calcium release from ER and 
mitochondria (Mironov et al., 2004; Wang et al., 2002) Thus, taxol may prevent axon 
degeneration by inhibiting pro-degeneration signalling from the soma or directly altering 
mitochondrial/ER coupling rather than frank protection of microtubule degradation, which 
may occur later by a calcium dependent process. 
In summary, our data indicate that somatodendritic excitotoxin exposure results in a 
benign calcium transient in the axon, which at higher concentrations of excitotoxin is 
likely followed by a soma to axonal signal resulting in a gradual increase in axonal 
calcium released from ER or mitochondrial stores and resulting in eventual fragmentation 
of the axon. 
Figure Legends
Figure 1. KA induced a rapid intra-axonal calcium peak followed by a long-term gradual 
calcium increase.  A. Axons of cultured cortical neurons loaded with calcium indicator 
Fluo-4 before (0 sec) and after somal KA treatment (5 sec and 10 sec). The arbitrary 
colour scale at the right indicates relative levels of calcium. Scale bar, 50 m. B. Example 
of spontaneous axonal calcium transients before KA treatment. C. Plot of relative calcium 
intensity changes in the axons after KA treatment for 30 sec. Mean ± SEM; n = 3 
independent cell culture preparations.  D. Plot of relative calcium intensity changes in the 
axons during the gradual phase after KA treatment. Mean ± SEM; n = 3 independent cell 
culture preparations.  E. Representative data showing the combination of the fast phase 
and gradual phase of axonal calcium increase after KA treatment.  F. Gradual axonal 
calcium alteration after KA or vehicle treatment for 90 mins. Arrows indicate the high 
calcium activity spots. 
Figure 2. KA induced axon degeneration and axonal calcium increase. A. Phase images 
of axons acquired before (0h) and after different dose of KA treatment (18h). Scale bar, 
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treatment. Mean ± SEM; n = 30 analyzed images; one-way ANOVA followed by Dunnett's 
multiple comparisons test; ***p < 0.001. C. Quantification of relative calcium peak 
intensity of initial calcium peak after kainic acid treatment. Mean ± SEM; n = 12 analyzed 
fields; one-way ANOVA followed by Dunnett's multiple comparisons test; ***p < 0.001. D. 
Quantification of relative calcium intensity at 60 min after KA treatment. Mean ± SEM; n = 
9 analyzed fields; one-way ANOVA followed by Dunnett's multiple comparisons test; *p < 
0.05, **p < 0.01. 
Figure 3. The regulation of fast phase and the gradual phase of axonal calcium increase. 
A. The initial calcium peak is prevented by tetrodotoxin but not Taxol. Axons of cortical 
neurons loaded with Fluo-4 before (T=0 sec) and after somal KA treatment (T= peak).  
Scale bar, 50 m. B. The gradual phase of axonal calcium changes with pre-treatment 
with tetrodotoxin and taxol. Axons of cortical neurons loaded with Fluo-4 before (0 min) 
and after somal KA treatment (30 min, 60 min, 90 min). Scale bar, 50 m. C. 
Quantification of initial calcium peak intensity. Mean ± SEM; n = 12 analyzed fields; one-
way ANOVA followed by Dunnett's multiple comparisons test; ***p < 0.001. D. Plot of 
relative calcium intensity changes in the axons during the gradual phase after KA 
treatment. Mean ± SEM; n = 9 analyzed fields. E. Quantification of relative calcium 
intensity at 90 min after KA treatment. Mean ± SEM; n = 9 analyzed fields; one-way 
ANOVA followed by Dunnett's multiple comparisons test; ***p < 0.001. F. Representative 
plots of gradual phase axonal calcium changes with pre-treatment with different dose of 
taxol. Mean ± SEM; n = 3 analyzed fields. G. Quantification of relative calcium intensity at 
30 min after KA treatment. Mean ± SEM; n = 12 analyzed fields; one-way ANOVA 
followed by Dunnett's multiple comparisons test; **p < 0.01. H&I. ELISA analyse of 
acetylated and tyrosinated tubulin levels at 2 hours after taxol (10 ng/ml) treatment. Mean 
± SEM; n = 5 independent cell culture preparations; one-way ANOVA followed by 
Dunnett's multiple comparisons test; *p < 0.05. 
Figure 4. The intra-axonal calcium store is the main source of somal KA induced axon 
degeneration. A. Treatment with either EGTA or BAPTA-AM prevents axonal rapid 
calcium peak induced by KA. Scale bar, 50 m. B. Quantification of relative calcium peak 
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multiple comparisons test; ***p < 0.001. C. The gradual phase of axonal calcium changes 
with pre-treatment with BAPTA and EGTA. Axons of cortical neurons loaded with Fluo-4 
before (0 min) and after somal KA treatment (30 min, 60 min). Scale bar, 50 m. D. Plot 
of relative calcium intensity changes in the axons during the gradual phase after KA 
treatment. Mean ± SEM; n = 9 analyzed fields. D. Quantification of relative calcium 
intensity at 60 min after KA treatment. Mean ± SEM; n = 9 analyzed fields; one-way 
ANOVA followed by Dunnett's multiple comparisons test; *p < 0.05. F. Phase images of 
axons acquired before (0h) and after different doses of KA treatment (18h). Scale bar, 50 
m. G. Percentage of axon degeneration normalized to Vehicle+KA. Mean ± SEM; n = 40 
analyzed images; one-way ANOVA followed by Dunnett's multiple comparisons test; ***p 
< 0.001.   
Figure 5. Inhibition of calcium release from intra-axonal ER and mitochondria prevent 
axonal calcium rise and degeneration. A. Axons pre-treated with 2APB, Dantrolene and 
Cyclosporin A  before (T=0 sec) and after (T=peak) KA treatment. Scale bar, 50 m. B. 
Quantification of relative calcium peak intensity. Mean ± SEM; n = 12 analyzed fields; 
one-way ANOVA followed by Dunnett's multiple comparisons test; *p < 0.05.  D. The 
gradual phase of axonal calcium changes with pre-treatment with Dantrolene and 
Cyclosporin A.  Axons of cortical neurons loaded with Fluo-4 before (0 min) and after 
somal KA treatment (30 min, 60 min, 90 min). Scale bar, 50 m. E. Plot of relative 
calcium intensity changes in the axons after KA treatment for 90 min. Mean ± SEM; n = 9 
analyzed fields. E. Quantification of relative calcium intensity at 90 min after KA treatment. 
Mean ± SEM; n = 9 analyzed fields.  F. Phase images of axons acquired before (0h) and 
after different dose of KA treatment (18h). Scale bar, 50 m.  G. Percentage of axon 
degeneration normalized to Vehicle+KA. Mean ± SEM; n = 40 analyzed images; one-way 












This article is protected by copyright. All rights reserved
Abdel-Hamid, K. M. and M. Tymianski (1997). "Mechanisms and effects of intracellular calcium 
buffering on neuronal survival in organotypic hippocampal cultures exposed to 
anoxia/aglycemia or to excitotoxins." J Neurosci 17(10): 3538-3553.
Adalbert, R., G. Morreale, M. Paizs, L. Conforti, S. A. Walker, H. L. Roderick, M. D. Bootman, L. 
Siklos and M. P. Coleman (2012). "Intra-axonal calcium changes after axotomy in wild-
type and slow Wallerian degeneration axons." Neuroscience 225: 44-54.
Allard, B. and O. Rougier (1992). "Reappraisal of the role of sodium ions in excitation-
contraction coupling in frog twitch muscle." J Muscle Res Cell Motil 13(1): 117-125.
Arduino, D. M. and F. Perocchi (2018). "Pharmacological modulation of mitochondrial calcium 
homeostasis." J Physiol 596(14): 2717-2733.
Arundine, M. and M. Tymianski (2003). "Molecular mechanisms of calcium-dependent 
neurodegeneration in excitotoxicity." Cell Calcium 34(4-5): 325-337.
Arundine, M. and M. Tymianski (2004). "Molecular mechanisms of glutamate-dependent 
neurodegeneration in ischemia and traumatic brain injury." Cell Mol Life Sci 61(6): 657-
668.
Barzan, R., F. Pfeiffer and M. Kukley (2016). "N- and L-Type Voltage-Gated Calcium Channels 
Mediate Fast Calcium Transients in Axonal Shafts of Mouse Peripheral Nerve." Front Cell 
Neurosci 10: 135.
Callewaert, G., J. Eilers and A. Konnerth (1996). "Axonal calcium entry during fast 'sodium' 
action potentials in rat cerebellar Purkinje neurones." J Physiol 495 (Pt 3): 641-647.
Cheng, C., D. M. Fass and I. J. Reynolds (1999). "Emergence of excitotoxicity in cultured 
forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)] (i) increases and 
NMDA receptor mRNA levels." Brain Res 849(1-2): 97-108.
Dowdy, S. C., S. Jiang, X. C. Zhou, X. Hou, F. Jin, K. C. Podratz and S. W. Jiang (2006). 
"Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and 
microtubule stabilization in papillary serous endometrial cancer cells." Mol Cancer Ther 
5(11): 2767-2776.
Ferreira, A. and E. H. Bigio (2011). "Calpain-mediated tau cleavage: a mechanism leading to 
neurodegeneration shared by multiple tauopathies." Mol Med. 17(7-8): 676-685. doi: 
610.2119/molmed.2010.00220. Epub 02011 Mar 00221.










This article is protected by copyright. All rights reserved
Hausenloy, D. J., S. B. Ong and D. M. Yellon (2009). "The mitochondrial permeability transition 
pore as a target for preconditioning and postconditioning." Basic Res Cardiol 104(2): 189-
202.
Heath, P. R. and P. J. Shaw (2002). "Update on the glutamatergic neurotransmitter system and 
the role of excitotoxicity in amyotrophic lateral sclerosis." Muscle Nerve 26(4): 438-458.
Hernandez, D. E., N. A. Salvadores, G. Moya-Alvarado, R. J. Catalan, F. C. Bronfman and F. A. 
Court (2018). "Axonal degeneration induced by glutamate excitotoxicity is mediated by 
necroptosis." J Cell Sci 131(22).
Hilliard, M. A. (2009). "Axonal degeneration and regeneration: a mechanistic tug-of-war." J 
Neurochem 108(1): 23-32.
Hosie, K. A., A. E. King, C. A. Blizzard, J. C. Vickers and T. C. Dickson (2012). "Chronic 
excitotoxin-induced axon degeneration in a compartmented neuronal culture model." 
ASN Neuro. 4(1).(pii): e00076. doi: 00010.01042/AN20110031.
Hoskison, M. M. and C. W. Shuttleworth (2006). "Microtubule disruption, not calpain-dependent 
loss of MAP2, contributes to enduring NMDA-induced dendritic dysfunction in acute 
hippocampal slices." Exp Neurol. 202(2): 302-312. Epub 2006 Aug 2010.
Hu, P. and R. G. Kalb (2003). "BDNF heightens the sensitivity of motor neurons to excitotoxic 
insults through activation of TrkB." J Neurochem 84(6): 1421-1430.
Jackson, V. M., S. J. Trout, K. L. Brain and T. C. Cunnane (2001). "Characterization of action 
potential-evoked calcium transients in mouse postganglionic sympathetic axon bundles." 
J Physiol 537(Pt 1): 3-16.
King, A. E., K. A. Southam, J. Dittmann and J. C. Vickers (2013). "Excitotoxin-induced caspase-
3 activation and microtubule disintegration in axons is inhibited by taxol." Acta 
Neuropathol Commun. 1(1): 59.
King, A. E., A. Woodhouse, M. T. Kirkcaldie and J. C. Vickers (2016). "Excitotoxicity in ALS: 
Overstimulation, or overreaction?" Exp Neurol 275 Pt 1: 162-171.
Knoferle, J., J. C. Koch, T. Ostendorf, U. Michel, V. Planchamp, P. Vutova, L. Tonges, C. 
Stadelmann, W. Bruck, M. Bahr and P. Lingor (2010). "Mechanisms of acute axonal 
degeneration in the optic nerve in vivo." Proc Natl Acad Sci U S A 107(13): 6064-6069.
Li, G., A. Faibushevich, B. J. Turunen, S. O. Yoon, G. Georg, M. L. Michaelis and R. T. 









This article is protected by copyright. All rights reserved
paclitaxel decreases beta-amyloid toxicity in cortical neurons." J Neurochem. 84(2): 347-
362.
Luarte, A., V. H. Cornejo, F. Bertin, J. Gallardo and A. Couve (2018). "The axonal endoplasmic 
reticulum: One organelle-many functions in development, maintenance, and plasticity." 
Dev Neurobiol 78(3): 181-208.
Matolcsi, M. and N. Giordano (2015). "A novel explanation for observed CaMKII dynamics in 
dendritic spines with added EGTA or BAPTA." Biophys J 108(4): 975-985
Matsuda, S. and S. Koyasu (2000). "Mechanisms of action of cyclosporine." 
Immunopharmacology 47(2-3): 119-125.
Mattson, M. P., F. M. LaFerla, S. L. Chan, M. A. Leissring, P. N. Shepel and J. D. Geiger (2000). 
"Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative 
disorders." Trends Neurosci 23(5): 222-229.
Micu, I., J. R. Plemel, C. Lachance, J. Proft, A. J. Jansen, K. Cummins, J. van Minnen and P. K. 
Stys (2016). "The molecular physiology of the axo-myelinic synapse." Exp Neurol 276: 
41-50.
Mironov, S. L., M. V. Ivannikov and M. Johansson (2005). "[Ca2+]i signaling between 
mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From 
mitochondrial permeability transition pore to Ca2+-induced Ca2+ release." J Biol Chem 
280(1): 715-721.
Mishra, B., R. Carson, R. I. Hume and C. A. Collins (2013). "Sodium and potassium currents 
influence Wallerian degeneration of injured Drosophila axons." J Neurosci 33(48): 18728-
18739.
Nikolaeva, M. A., B. Mukherjee and P. K. Stys (2005). "Na+-dependent sources of intra-axonal 
Ca2+ release in rat optic nerve during in vitro chemical ischemia." J Neurosci 25(43): 
9960-9967.
O'Brien, E. T., E. D. Salmon and H. P. Erickson (1997). "How calcium causes microtubule 
depolymerization." Cell Motil Cytoskeleton 36(2): 125-135.
Ouardouz, M., M. A. Nikolaeva, E. Coderre, G. W. Zamponi, J. E. McRory, B. D. Trapp, X. Yin, 
W. Wang, J. Woulfe and P. K. Stys (2003). "Depolarization-induced Ca2+ release in 
ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine 









This article is protected by copyright. All rights reserved
Pellegrini-Giampietro, D. E., J. A. Gorter, M. V. Bennett and R. S. Zukin (1997). "The GluR2 
(GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders." 
Trends Neurosci 20(10): 464-470.
Rizzuto, R., P. Pinton, W. Carrington, F. S. Fay, K. E. Fogarty, L. M. Lifshitz, R. A. Tuft and T. 
Pozzan (1998). "Close contacts with the endoplasmic reticulum as determinants of 
mitochondrial Ca2+ responses." Science 280(5370): 1763-1766
Ruiz, A., C. Matute and E. Alberdi (2009). "Endoplasmic reticulum Ca(2+) release through 
ryanodine and IP(3) receptors contributes to neuronal excitotoxicity." Cell Calcium 46(4): 
273-281.
Sargoy, A., X. Sun, S. Barnes and N. C. Brecha (2014). "Differential calcium signaling mediated 
by voltage-gated calcium channels in rat retinal ganglion cells and their unmyelinated 
axons." PLoS One 9(1): e84507.
Staal, J. A., T. C. Dickson, R. Gasperini, Y. Liu, L. Foa and J. C. Vickers (2010). "Initial calcium 
release from intracellular stores followed by calcium dysregulation is linked to secondary 
axotomy following transient axonal stretch injury." J Neurochem.
Stys, P. K. and R. M. Lopachin (1998). "Mechanisms of calcium and sodium fluxes in anoxic 
myelinated central nervous system axons." Neuroscience 82(1): 21-32.
Szydlowska, K. and M. Tymianski (2010). "Calcium, ischemia and excitotoxicity." Cell Calcium. 
47(2): 122-129. doi: 110.1016/j.ceca.2010.1001.1003. Epub 2010 Feb 1018.
Tymianski, M., I. Spigelman, L. Zhang, P. L. Carlen, C. H. Tator, M. P. Charlton and M. C. 
Wallace (1994). "Mechanism of action and persistence of neuroprotection by cell-
permeant Ca2+ chelators." J Cereb Blood Flow Metab 14(6): 911-923.
Tymianski, M. and C. H. Tator (1996). "Normal and abnormal calcium homeostasis in neurons: 
a basis for the pathophysiology of traumatic and ischemic central nervous system injury." 
Neurosurgery 38(6): 1176-1195.
Vargas, M. E., Y. Yamagishi, M. Tessier-Lavigne and A. Sagasti (2015). "Live Imaging of 
Calcium Dynamics during Axon Degeneration Reveals Two Functionally Distinct Phases 
of Calcium Influx." J Neurosci 35(45): 15026-15038.
Vickers, J. C., A. E. King, A. Woodhouse, M. T. Kirkcaldie, J. A. Staal, G. H. McCormack, C. A. 
Blizzard, R. E. Musgrove, S. Mitew, Y. Liu, J. A. Chuckowree, O. Bibari and T. C. Dickson 
(2009). "Axonopathy and cytoskeletal disruption in degenerative diseases of the central 









This article is protected by copyright. All rights reserved
Villegas, R., N. W. Martinez, J. Lillo, P. Pihan, D. Hernandez, J. L. Twiss and F. A. Court (2014). 
"Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration 
through mitochondrial dysfunction." J Neurosci 34(21): 7179-7189.
Wang, J. T., Z. A. Medress and B. A. Barres (2012). "Axon degeneration: molecular 
mechanisms of a self-destruction pathway." J Cell Biol 196(1): 7-18.
Wang, R. and P. H. Reddy (2017). "Role of Glutamate and NMDA Receptors in Alzheimer's 
Disease." J Alzheimers Dis 57(4): 1041-1048.
Wu, Y., C. Whiteus, C. S. Xu, K. J. Hayworth, R. J. Weinberg, H. F. Hess and P. De Camilli 
(2017). "Contacts between the endoplasmic reticulum and other membranes in neurons." 
Proc Natl Acad Sci U S A 114(24): E4859-e4867.
Wang, Y., M. P. Mattson and K. Furukawa (2002). "Endoplasmic reticulum calcium release is 
modulated by actin polymerization." Journal of Neurochemistry 82(4): 945-952.
Yang, J., R. M. Weimer, D. Kallop, O. Olsen, Z. Wu, N. Renier, K. Uryu and M. Tessier-Lavigne 
(2013). "Regulation of axon degeneration after injury and in development by the 
endogenous calpain inhibitor calpastatin." Neuron 80(5): 1175-1189.
Yawo, H. and M. Kuno (1985). "Calcium dependence of membrane sealing at the cut end of the 
cockroach giant axon." J Neurosci 5(6): 1626-1632.
Ying, Z., G. Xiang, L. Zheng, H. Tang, L. Duan, X. Lin, Q. Zhao, K. Chen, Y. Wu, G. Xing, Y. Lv, 
L. Li, L. Yang, F. Bao, Q. Long, Y. Zhou, X. He, Y. Wang, M. Gao, D. Pei, W. Y. Chan 
and X. Liu (2018). "Short-Term Mitochondrial Permeability Transition Pore Opening 
Modulates Histone Lysine Methylation at the Early Phase of Somatic Cell 
Reprogramming." Cell Metab.
Yu, S. P. and D. W. Choi (1997). "Na(+)-Ca2+ exchange currents in cortical neurons: 
concomitant forward and reverse operation and effect of glutamate." Eur J Neurosci 9(6): 
1273-1281.
Zhang, Z., A. K. Ottens, S. Sadasivan, F. H. Kobeissy, T. Fang, R. L. Hayes and K. K. Wang 
(2007). "Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis 











This article is protected by copyright. All rights reserved
If yes: Informed consent & ethics approval achieved:
=> if yes, please ensure that the info "Informed consent was achieved for all 
subjects, and the experiments were approved by the local ethics committee." is 
included in the Methods.
ARRIVE guidelines have been followed:
Yes
=> if it is a Review or Editorial, skip complete sentence => if No, include a 
statement: "ARRIVE guidelines were not followed for the following reason:
"
(edit phrasing to form a complete sentence as necessary).
=> if Yes, insert "All experiments were conducted in compliance with the ARRIVE 
guidelines." unless it is a Review or Editorial
Acknowledgements/ Conflict of interest disclosure
This research was funded by an NHMRC project grant (APP1085221) to AK, AC and JV, 
the JO and JR Wicking Trust (Equity Trustees) and the Yulgilbar Foundation. The authors 





















































































































































































































































































































































































C      D      
Fig 3
E      



































































































































































































































































































Vehicle Vehicle+KA BAPTA+KA EGTA+KA
A            B            
C            
D            E            

















































































































































































E0 30 60 90
0
2
4
6
8
Time (min)
(F
-F
0
)/
F
0
Vehicle+KA
Dantrolene+KA
CsA+KA
E
CsA+KA
C
Vehicle+KA Dantrolene+KA CsA+KA
0
 m
in
3
0
 m
in
6
0
 m
in
9
0
 m
in
T
im
e
 a
ft
e
r 
K
A
 
Ve
hi
cl
e
Ve
hi
cl
e+
K
A
D
an
tr
ol
en
e+
K
A
C
sA
+K
A
0
30
60
90
120
D
e
g
e
n
e
ra
ti
o
n
 (
%
 V
e
h
ic
le
+
K
A
)
*** ***
0
 h
1
8
 h
Vehicle+KA Dantrolene+KA CsA+KAVehicleF
Ve
hi
cl
e+
K
A
2A
P
B
+K
A
D
an
tr
ol
en
e+
K
A
C
sA
+K
A
0.0
0.5
1.0
1.5
(F
-F
0
)/
F
0
, 
p
e
a
k
 a
m
p
li
tu
d
e
*
Ve
hi
cl
e+
K
A
D
an
tr
ol
en
e+
K
A
C
sA
+K
A
0
2
4
6
8
10
p
e
a
k
 a
m
p
li
tu
d
e
 a
t 
9
0
 m
in
* *
jnc_14909_f5.eps
This	article	is	protected	by	copyright.	All	rights	reserved
A
cc
ep
te
d 
A
rt
ic
le
